NBY
Price
$13.00
Change
+$0.27 (+2.12%)
Updated
Jan 15, 11:54 AM (EDT)
Capitalization
1.6B
Intraday BUY SELL Signals
ZNTL
Price
$3.34
Change
-$0.17 (-4.84%)
Updated
Jan 15, 12:26 PM (EDT)
Capitalization
254.32M
48 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NBY vs ZNTL

Header iconNBY vs ZNTL Comparison
Open Charts NBY vs ZNTLBanner chart's image
NovaBay Pharmaceuticals
Price$13.00
Change+$0.27 (+2.12%)
Volume$1.5K
Capitalization1.6B
Zentalis Pharmaceuticals
Price$3.34
Change-$0.17 (-4.84%)
Volume$2.92K
Capitalization254.32M
NBY vs ZNTL Comparison Chart in %
NBY
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
NBY vs. ZNTL commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBY is a Hold and ZNTL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (NBY: $12.73 vs. ZNTL: $3.51)
Brand notoriety: NBY and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NBY: 54% vs. ZNTL: 73%
Market capitalization -- NBY: $1.6B vs. ZNTL: $254.32M
NBY [@Biotechnology] is valued at $1.6B. ZNTL’s [@Biotechnology] market capitalization is $254.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NBY’s FA Score shows that 2 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • NBY’s FA Score: 2 green, 3 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, NBY is a better buy in the long-term than ZNTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NBY’s TA Score shows that 3 TA indicator(s) are bullish while ZNTL’s TA Score has 7 bullish TA indicator(s).

  • NBY’s TA Score: 3 bullish, 4 bearish.
  • ZNTL’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, ZNTL is a better buy in the short-term than NBY.

Price Growth

NBY (@Biotechnology) experienced а +19.64% price change this week, while ZNTL (@Biotechnology) price change was +45.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.23%. For the same industry, the average monthly price growth was +2.54%, and the average quarterly price growth was +43.40%.

Reported Earning Dates

ZNTL is expected to report earnings on Mar 04, 2026.

Industries' Descriptions

@Biotechnology (-0.23% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NBY($1.6B) has a higher market cap than ZNTL($254M). ZNTL YTD gains are higher at: 160.000 vs. NBY (125.709). NBY has higher annual earnings (EBITDA): -6.59M vs. ZNTL (-152.83M). ZNTL has more cash in the bank: 281M vs. NBY (2.31M). NBY has less debt than ZNTL: NBY (970K) vs ZNTL (36.7M). ZNTL has higher revenues than NBY: ZNTL (26.9M) vs NBY (10.3M).
NBYZNTLNBY / ZNTL
Capitalization1.6B254M631%
EBITDA-6.59M-152.83M4%
Gain YTD125.709160.00079%
P/E Ratio2.47N/A-
Revenue10.3M26.9M38%
Total Cash2.31M281M1%
Total Debt970K36.7M3%
FUNDAMENTALS RATINGS
NBY: Fundamental Ratings
NBY
OUTLOOK RATING
1..100
30
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NBYZNTL
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 9 days ago
82%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
NBY
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
COVAX13.470.06
+0.45%
Columbia Sm Cp Val and Inflection A
PVFAX51.160.06
+0.12%
Paradigm Value
NAEFX77.77-0.09
-0.12%
New Alternatives Investor
OGICX41.12-0.06
-0.15%
Invesco Global Opportunities C
LMPLX53.34-0.73
-1.35%
ClearBridge Large Cap Growth R

NBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, NBY has been loosely correlated with ATON. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NBY jumps, then ATON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NBY
1D Price
Change %
NBY100%
-2.38%
ATON - NBY
38%
Loosely correlated
-29.47%
NEVPF - NBY
34%
Loosely correlated
N/A
ALT - NBY
30%
Poorly correlated
+4.24%
ORMP - NBY
29%
Poorly correlated
+7.37%
ZNTL - NBY
28%
Poorly correlated
+0.86%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with RVMD. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then RVMD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
+0.86%
RVMD - ZNTL
47%
Loosely correlated
+1.06%
ERAS - ZNTL
47%
Loosely correlated
+10.73%
CGON - ZNTL
44%
Loosely correlated
+5.57%
IPSC - ZNTL
43%
Loosely correlated
-6.05%
ELVN - ZNTL
41%
Loosely correlated
+1.17%
More